These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 19838647)

  • 1. Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes. A novel pleiotropic effect?
    Tziakas DN; Chalikias GK; Stakos D; Tentes IK; Thomaidi A; Chatzikyriakou S; Mitrousi K; Kortsaris AX; Kaski JC; Boudoulas H; Konstantinides S
    Cardiovasc Drugs Ther; 2009 Dec; 23(6):471-80. PubMed ID: 19838647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability?
    Tziakas DN; Kaski JC; Chalikias GK; Romero C; Fredericks S; Tentes IK; Kortsaris AX; Hatseras DI; Holt DW
    J Am Coll Cardiol; 2007 May; 49(21):2081-9. PubMed ID: 17531656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol composition of erythrocyte membranes and its association with clinical presentation of coronary artery disease.
    Tziakas DN; Chalikias GK; Stakos D; Tentes IK; Chatzikyriakou SV; Mitrousi K; Kortsaris AX; Boudoulas H; Kaski JC
    Coron Artery Dis; 2008 Dec; 19(8):583-90. PubMed ID: 19005293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation.
    Tziakas DN; Chalikias GK; Stakos D; Tentes IK; Papazoglou D; Thomaidi A; Grapsa A; Gioka G; Kaski JC; Boudoulas H
    Int J Cardiol; 2011 Jul; 150(1):22-7. PubMed ID: 20223535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin.
    Zhong Y; Tang H; Zeng Q; Wang X; Yi G; Meng K; Mao Y; Mao X
    Ups J Med Sci; 2012 Nov; 117(4):390-8. PubMed ID: 23009223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell distribution width: a strong prognostic marker in cardiovascular disease: is associated with cholesterol content of erythrocyte membrane.
    Tziakas D; Chalikias G; Grapsa A; Gioka T; Tentes I; Konstantinides S
    Clin Hemorheol Microcirc; 2012; 51(4):243-54. PubMed ID: 22277951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome.
    Tziakas DN; Chalikias GK; Tentes IK; Stakos D; Chatzikyriakou SV; Mitrousi K; Kortsaris AX; Kaski JC; Boudoulas H
    Eur Heart J; 2008 Nov; 29(22):2713-22. PubMed ID: 18765457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: modulatory effects of rosuvastatin.
    Tziakas D; Chalikias G; Kapelouzou A; Tentes I; Schäfer K; Karayannakos P; Kostakis A; Boudoulas H; Konstantinides S
    Int J Cardiol; 2013 Dec; 170(2):173-81. PubMed ID: 24215985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total cholesterol content of erythrocyte membranes levels are associated with the presence of acute coronary syndrome and high sensitivity C-reactive protein.
    Yu MM; Xu Y; Zhang JH; Wang CH; Wang XC; Cheng ZP; Xu BL
    Int J Cardiol; 2010 Nov; 145(1):57-8. PubMed ID: 19411120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of total cholesterol content of erythrocyte membranes in patients with acute coronary syndrome].
    Zhang JH; Wang CH; Xu J; Ye L; Wang XC; Xu BL; Chen XH; Wu MZ; Cheng ZP; Xu Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):305-310. PubMed ID: 31060190
    [No Abstract]   [Full Text] [Related]  

  • 11. Sphingomyelin in erythrocyte membranes increases the total cholesterol content of erythrocyte membranes in patients with acute coronary syndrome.
    Zhang J; Tu K; Xu Y; Pan L; Wu C; Chen X; Wu M; Cheng Z; Chen B
    Coron Artery Dis; 2013 Aug; 24(5):361-7. PubMed ID: 23652364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy.
    Miedema MD; Conover CA; MacDonald H; Harrington SC; Oberg D; Wilson D; Henry TD; Schwartz RS
    Am J Cardiol; 2008 Jan; 101(1):35-9. PubMed ID: 18157962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the efficacy of statin treatment in acute coronary syndromes.
    Rosa GM; Carbone F; Parodi A; Massimelli EA; Brunelli C; Mach F; Vuilleumier N; Montecucco F
    Eur J Clin Invest; 2014 May; 44(5):501-15. PubMed ID: 24601937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.
    Marenzi G; Cosentino N; Werba JP; Tedesco CC; Veglia F; Bartorelli AL
    Int J Cardiol; 2015 Mar; 183():47-53. PubMed ID: 25662053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of switching from intensive to moderate statin therapy after acute coronary syndromes.
    Colivicchi F; Tubaro M; Santini M
    Int J Cardiol; 2011 Oct; 152(1):56-60. PubMed ID: 20674999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total cholesterol content of erythrocyte membranes and coronary atherosclerosis: an intravascular ultrasound pilot study.
    Giannoglou GD; Koskinas KC; Tziakas DN; Ziakas AG; Antoniadis AP; Tentes IK; Parcharidis GE
    Angiology; 2009 Dec-2010 Jan; 60(6):676-82. PubMed ID: 19541664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid parameters in patients with acute coronary syndromes versus stable coronary artery disease.
    Vonbank A; Saely CH; Rein P; Drexel H
    Eur J Clin Invest; 2015 Oct; 45(10):1092-7. PubMed ID: 26255620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
    Schwartz GG; Abt M; Bao W; DeMicco D; Kallend D; Miller M; Mundl H; Olsson AG
    J Am Coll Cardiol; 2015 Jun; 65(21):2267-75. PubMed ID: 26022813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.